FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, particularly an agent able to inhibit immune response underlying immunoglobulin-E-dependent allergic diseases. Application of water-soluble polysaccharides made of Acorns calamus L. root, as an agent able to inhibit immune response underlying immunoglobulin-E-dependent allergic diseases.
EFFECT: said polysaccharides made of Acorns calamus L root are able to inhibit the first-stage development of immunoglobulin-E-dependent allergies that cause reduced synthesis of immunoglobulins classes E and G1 that ensures inhibition of further events related to development and release of biologically active substances taking a damaging action on cells and tissues.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIALLERGIC PREPARATION | 2008 |
|
RU2379047C1 |
| AGENT OF ANTIALLERGIC ACTION | 2007 |
|
RU2337699C1 |
| AGENT BASED ON WATER-SOLUBLE VEGETABLE POLYSACCHARIDES, HAVING ANTIALLERGIC ACTIVITY | 2023 |
|
RU2823873C1 |
| AGENT ELICITING ANTI-ALLERGIC EFFECT | 2003 |
|
RU2240801C1 |
| PRODUCT OF HUMIC NATURE WITH ANTI-ALLERGIC ACTIVITY | 2020 |
|
RU2750098C1 |
| IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
| METHOD FOR PRODUCING POLARIZED LYMPHOCYTES FOR MODELING Th2-INDUCED EDEMA | 2006 |
|
RU2318525C1 |
| MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
| IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
| DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
Authors
Dates
2010-01-10—Published
2008-06-16—Filed